Literature DB >> 34273716

Phosphorescent rhenium(I) complexes conjugated with artesunate: Mitochondrial targeting and apoptosis-ferroptosis dual induction.

Rui-Rong Ye1, Bi-Chun Chen2, Jun-Jian Lu2, Xiu-Rong Ma2, Rong-Tao Li3.   

Abstract

Cell death is essential for cancer, which can be induced through multiple mechanisms. Ferroptosis, a newly emerging form of non-apoptotic cell death, involves the generation of iron-dependent reactive oxygen species (ROS). In this study, we designed and synthesized two artesunate (ART) conjugated phosphorescent rhenium(I) complexes (Re(I)-ART conjugates), [Re(N^N)(CO)3(PyCH2OART)](PF6) (Re-ART-1 and Re-ART-2) (Py = pyridine, N^N = 1,10-phenanthroline (phen, in Re-ART-1) and 4,7-diphenyl-1,10-phenanthroline (DIP, in Re-ART-2)) that can specifically locate in the mitochondria of human cervical carcinoma (HeLa). Mechanism studies show that Re-ART-1 and Re-ART-2 exhibit high cytotoxicity against cancer cells lines and can induce both apoptosis and ferroptosis in HeLa cells through mitochondrial damage, caspase cascade, glutathione (GSH) depletion, glutathione peroxidase 4 (GPX4) inactivation and lipid peroxidation accumulation. As a result, this work presents the rational design of Re(I)-ART conjugates as a promising strategy to induce both apoptosis and ferroptosis and improve therapeutic efficiency of cancer treatment.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anticancer activity; Apoptosis; Artesunate; Ferroptosis; Mitochondria; Rhenium(I) complex

Mesh:

Substances:

Year:  2021        PMID: 34273716     DOI: 10.1016/j.jinorgbio.2021.111537

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  6 in total

Review 1.  New Insights on Ferroptosis and Gynecological Malignancies.

Authors:  Ruiqi Fan; Yujun Sun; Mengxue Wang; Qian Wang; Aifang Jiang; Tingting Yang
Journal:  Front Mol Biosci       Date:  2022-06-14

2.  Synthesis, Characterization and Antitumor Mechanism Investigation of Heterometallic Ru(Ⅱ)-Re(Ⅰ) Complexes.

Authors:  Xiurong Ma; Junjian Lu; Peixin Yang; Bo Huang; Rongtao Li; Ruirong Ye
Journal:  Front Chem       Date:  2022-05-27       Impact factor: 5.545

Review 3.  Metal Complexes or Chelators with ROS Regulation Capacity: Promising Candidates for Cancer Treatment.

Authors:  Xiang Li; Yuhui Wang; Man Li; Huipeng Wang; Xiongwei Dong
Journal:  Molecules       Date:  2021-12-27       Impact factor: 4.411

Review 4.  Anticancer and Antibiotic Rhenium Tri- and Dicarbonyl Complexes: Current Research and Future Perspectives.

Authors:  Kevin Schindler; Fabio Zobi
Journal:  Molecules       Date:  2022-01-15       Impact factor: 4.411

5.  Synthesis, Characterization and Anticancer Efficacy Evaluation of Benzoxanthone Compounds toward Gastric Cancer SGC-7901.

Authors:  Yuan Fu; Yunran Xu; Yunjun Liu; Yi Wang; Ju Chen; Xiuzhen Wang
Journal:  Molecules       Date:  2022-03-18       Impact factor: 4.411

Review 6.  Photoactive and Luminescent Transition Metal Complexes as Anticancer Agents: A Guiding Light in the Search for New and Improved Cancer Treatments.

Authors:  Brondwyn S McGhie; Janice R Aldrich-Wright
Journal:  Biomedicines       Date:  2022-03-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.